2017 Q2 Form 10-Q Financial Statement
#000156459018020760 Filed on August 09, 2018
Income Statement
| Concept | 2017 Q2 |
|---|---|
| Revenue | $1.479M |
| YoY Change | 7.72% |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | $2.360M |
| YoY Change | -3.67% |
| % of Gross Profit | |
| Research & Development | $5.835M |
| YoY Change | 32.01% |
| % of Gross Profit | |
| Depreciation & Amortization | $60.00K |
| YoY Change | 100.0% |
| % of Gross Profit | |
| Operating Expenses | $8.199M |
| YoY Change | 19.38% |
| Operating Profit | -$6.720M |
| YoY Change | 22.29% |
| Interest Expense | $100.0K |
| YoY Change | 42.86% |
| % of Operating Profit | |
| Other Income/Expense, Net | $88.00K |
| YoY Change | 35.38% |
| Pretax Income | -$6.630M |
| YoY Change | 22.1% |
| Income Tax | |
| % Of Pretax Income | |
| Net Earnings | -$6.632M |
| YoY Change | 22.14% |
| Net Earnings / Revenue | -448.41% |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$469.9K |
| COMMON SHARES | |
| Basic Shares Outstanding | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q2 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $63.40M |
| YoY Change | -13.86% |
| Cash & Equivalents | $26.93M |
| Short-Term Investments | $36.50M |
| Other Short-Term Assets | $1.600M |
| YoY Change | -11.11% |
| Inventory | |
| Prepaid Expenses | |
| Receivables | $1.200M |
| Other Receivables | $0.00 |
| Total Short-Term Assets | $66.20M |
| YoY Change | -13.92% |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | $802.0K |
| YoY Change | 112.73% |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | |
| YoY Change | |
| Other Assets | $139.0K |
| YoY Change | 672.22% |
| Total Long-Term Assets | $941.0K |
| YoY Change | 138.23% |
| TOTAL ASSETS | |
| Total Short-Term Assets | $66.20M |
| Total Long-Term Assets | $941.0K |
| Total Assets | $67.14M |
| YoY Change | -13.14% |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $634.0K |
| YoY Change | 82.18% |
| Accrued Expenses | $3.700M |
| YoY Change | 23.33% |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $0.00 |
| YoY Change | |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $4.418M |
| YoY Change | 29.94% |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $0.00 |
| YoY Change | |
| Other Long-Term Liabilities | $122.0K |
| YoY Change | |
| Total Long-Term Liabilities | $122.0K |
| YoY Change | |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $4.418M |
| Total Long-Term Liabilities | $122.0K |
| Total Liabilities | $4.540M |
| YoY Change | 33.53% |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | -$58.16M |
| YoY Change | 73.31% |
| Common Stock | $2.000K |
| YoY Change | 100.0% |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $62.60M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $67.14M |
| YoY Change | -13.14% |
Cashflow Statement
| Concept | 2017 Q2 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$6.632M |
| YoY Change | 22.14% |
| Depreciation, Depletion And Amortization | $60.00K |
| YoY Change | 100.0% |
| Cash From Operating Activities | -$5.940M |
| YoY Change | 28.29% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | -$50.00K |
| YoY Change | -44.44% |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | $4.570M |
| YoY Change | 135.57% |
| Cash From Investing Activities | $4.520M |
| YoY Change | 144.32% |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 11.55M |
| YoY Change | -76.61% |
| NET CHANGE | |
| Cash From Operating Activities | -5.940M |
| Cash From Investing Activities | 4.520M |
| Cash From Financing Activities | 11.55M |
| Net Change In Cash | 10.13M |
| YoY Change | -78.27% |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$5.940M |
| Capital Expenditures | -$50.00K |
| Free Cash Flow | -$5.890M |
| YoY Change | 29.74% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2378000 | |
| CY2017Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1479000 | |
| CY2017Q2 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:GrantMember | |
| CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
8199000 | |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
14114101 | |
| CY2017Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
8000 | |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6632000 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.47 | |
| CY2017Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6624000 | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
145000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
114000 | ||
| agle |
Payment For Discount Premium On Investments Net
PaymentForDiscountPremiumOnInvestmentsNet
|
-401000 | ||
| agle |
Payment For Discount Premium On Investments Net
PaymentForDiscountPremiumOnInvestmentsNet
|
40000 | ||
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
107000 | ||
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
-80000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1831000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1066000 | ||
| us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
41000 | ||
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
20000 | ||
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
13000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1203000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
573000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-29000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
579000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
340000 | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-20000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-73000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11374000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
317000 | ||
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
37780000 | ||
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
17010000 | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such management estimates include those related to accruals of research and development related costs, stock-based compensation, and certain company income tax related items. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</p></div> | ||
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company’s investment policy limits investments to high credit quality securities issued by the U.S. government, U.S. government-sponsored agencies and highly rated banks, subject to certain concentration limits and restrictions on maturities. The Company’s cash, cash equivalents, and marketable securities are held by financial institutions in the United States that management believes are of high credit quality. Amounts on deposit may at times exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents and its accounts are monitored by management to mitigate risk. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash and cash equivalents and bond issuers.</p></div> | ||
| us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | ||
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | ||
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | ||
| CY2018Q2 | agle |
Number Of Subsidiary Corporations Owned
NumberOfSubsidiaryCorporationsOwned
|
7 | |
| CY2018Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
19047000 | |
| CY2018Q2 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
19048000 | |
| CY2018Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
51670000 | |
| CY2018Q2 | agle |
Working Capital
WorkingCapital
|
72700000 | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
72200000 | |
| us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | ||
| CY2018Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
8000 | |
| CY2018Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
64000 | |
| CY2018Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
51614000 | |
| CY2017Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
8924000 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
8924000 | |
| CY2017Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
37584000 | |
| CY2017Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
102000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
37482000 | |
| CY2018Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
51614000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
34498000 | |
| CY2017Q4 | agle |
Available For Sale Securities Debt Maturities Year One Through Two Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearOneThroughTwoFairValue
|
2984000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
37482000 | |
| CY2018Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
1370000 | |
| CY2018Q2 | agle |
Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
|
3155000 | |
| CY2018Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
623000 | |
| CY2018Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
75000 | |
| CY2018Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
0 | |
| CY2018Q2 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 |
